The WHO’s COVID-19 Technology Access Pool (C-TAP) and the UN-backed Medicines Patent Pool on Aug. 29 announced a licensing agreement with Taiwan’s Medigen Vaccine Biologics Corp to make the company’s COVID-19 vaccine accessible worldwide to people in need.
This is the first time a Taiwanese vaccine manufacturer has used the WHO patent access model to offer its know-how for a COVID-19 vaccine to the world. WHO Director-General Tedros Adhanom Ghebreyesus expressed his gratitude to Medigen for sharing its patent to support countries in fighting the disease.
Toxicology results, animal and clinical trial data, as well as production data, were required to enter the C-TAP pool, similar to how Taiwanese officials in 2021 assessed and granted emergency use authorization (EUA) for the product.
Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) said that the WHO’s addition of Medigen’s vaccine, which has been administered more than 3 million times in seven countries, means that the global body has authorized and endorsed a Taiwan-made vaccine, and was an affirmation of the nation’s vaccine industry. This is a validation of Medigen after the harsh criticism it has endured from Taiwanese opposition parties over the past few years.
There are also lessons to learn about the restoration of justice for vaccine development and manufacturing in Taiwan.
During the COVID-19 pandemic, China weaponized vaccines to advance its geopolitical agenda and influence politics in Taiwan. Beijing not only barred vaccines produced by foreign manufacturers and limited its people to its domestic vaccines, it also sought to block Taiwan’s vaccine procurement, including by delaying delivery of an order for BioNTech vaccines. These actions aimed to inflict political damage on President Tsai Ing-wen’s (蔡英文) administration while promoting Chinese-made vaccines to facilitate its “united front” work.
Ironically, despite surveys showing that more than 80 percent of Taiwanese were not willing to be inoculated with China-made vaccines, some opposition politicians, notably from the Chinese Nationalist Party (KMT), and pro-China media influencers badgered the government to buy Chinese vaccines, while lashing out at Taiwan’s domestically produced vaccine and stigmatizing efforts to foster an indigenous biotech industry.
International researchers have shown that Taiwan-made vaccines are effective against COVID-19. A transnational study published in a Swiss medical journal found that Medigen’s vaccine has an efficacy of 84 percent, far better than Chinese vaccines, which were rated only 65 percent effective.
While the Food and Drug Administration was criticized for granting Medigen an EUA based on immunobridging, many WHO-validated vaccines used the same standard to issue EUAs. Studies have also shown that Medigen’s protein subunit vaccine has fewer adverse reactions than mRNA COVID-19 vaccines.
The Medigen story is a reminder that the scientific process should prevail over political mudslinging.
Political attacks have intensified in the run-up to the presidential and legislative elections in January, with slogans such as “Electing the Democratic Progressive Party will cause war” — even as China continues with its military posturing in the Taiwan Strait.
Just as collective immunity against a virus is required to protect public health when a pandemic hits, collective awareness and wisdom are required as the elections draw near to guard against disinformation and stigmatization, and protect Taiwan’s democracy and sovereignty.
Minister of Labor Hung Sun-han (洪申翰) on April 9 said that the first group of Indian workers could arrive as early as this year as part of a memorandum of understanding (MOU) between the Taipei Economic and Cultural Center in India and the India Taipei Association. Signed in February 2024, the MOU stipulates that Taipei would decide the number of migrant workers and which industries would employ them, while New Delhi would manage recruitment and training. Employment would be governed by the laws of both countries. Months after its signing, the two sides agreed that 1,000 migrant workers from India would
In recent weeks, Taiwan has witnessed a surge of public anxiety over the possible introduction of Indian migrant workers. What began as a policy signal from the Ministry of Labor quickly escalated into a broader controversy. Petitions gathered thousands of signatures within days, political figures issued strong warnings, and social media became saturated with concerns about public safety and social stability. At first glance, this appears to be a straightforward policy question: Should Taiwan introduce Indian migrant workers or not? However, this framing is misleading. The current debate is not fundamentally about India. It is about Taiwan’s labor system, its
On March 31, the South Korean Ministry of Foreign Affairs released declassified diplomatic records from 1995 that drew wide domestic media attention. One revelation stood out: North Korea had once raised the possibility of diplomatic relations with Taiwan. In a meeting with visiting Chinese officials in May 1995, as then-Chinese president Jiang Zemin (江澤民) prepared for a visit to South Korea, North Korean officials objected to Beijing’s growing ties with Seoul and raised Taiwan directly. According to the newly released records, North Korean officials asked why Pyongyang should refrain from developing relations with Taiwan while China and South Korea were expanding high-level
Japan’s imminent easing of arms export rules has sparked strong interest from Warsaw to Manila, Reuters reporting found, as US President Donald Trump wavers on security commitments to allies, and the wars in Iran and Ukraine strain US weapons supplies. Japanese Prime Minister Sanae Takaichi’s ruling party approved the changes this week as she tries to invigorate the pacifist country’s military industrial base. Her government would formally adopt the new rules as soon as this month, three Japanese government officials told Reuters. Despite largely isolating itself from global arms markets since World War II, Japan spends enough on its own
RSS